Skip to main content
. Author manuscript; available in PMC: 2020 Nov 8.
Published in final edited form as: Vaccine. 2019 Jul 16;37(47):6942–6950. doi: 10.1016/j.vaccine.2019.06.035

Figure 1: Immunogenicity in guinea pigs.

Figure 1:

Geometric mean titers (GMT+95%CI) of EBOV GP-specific IgG determined using ELISA in serum from guinea pigs following the first (A), second (B) and third (C) vaccine dose for each adjuvant and antigen formulation. Serum samples were collected 3 weeks following each vaccination. Statistical significance was determine using an unpaired t-test (*p<0.05, **p<0.01, ***p<0.001). The control group received GPI-0100 adjuvant only. The negative assay cutoff is indicated by the dotted line.